C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-β/smad3 and IKBα Pathway

Title
C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-β/smad3 and IKBα Pathway
Authors
Keywords
Collagens, Kidneys, Type 2 diabetes, Complement receptors, Complement system, Diabetes mellitus, Transcription factors, Inflammation
Journal
PLoS One
Volume 9, Issue 11, Pages e113639
Publisher
Public Library of Science (PLoS)
Online
2014-11-26
DOI
10.1371/journal.pone.0113639

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now